Literature DB >> 2507442

Characterization of a translocation within the von Recklinghausen neurofibromatosis region of chromosome 17.

A G Menon1, D H Ledbetter, D C Rich, B R Seizinger, G A Rouleau, V F Michels, M A Schmidt, G Dewald, C M DallaTorre, J L Haines.   

Abstract

The genetic defect causing von Recklinghausen neurofibromatosis (NF1) has been mapped to the proximal long arm of chromosome 17 by linkage analysis. Flanking markers have been identified, bracketing NF1 in 17q11.2 and laying the foundation for isolating the disease gene. Recently, a family in which a mother and her two children show both the symptoms of NF1 and the presence of a balanced translocation, t(1;17)(p34.3;q11.2), has been identified. We have examined the possibility that the translocation has occurred in or near the NF1 gene by constructing a somatic cell hybrid line containing the derivative chromosome 1 (1qter-p34.3::17q11-qter). On chromosome 1, the breakpoint occurred between SRC2 and D1S57, which are separated by 14 cM. The translocation breakpoint was localized on chromosome 17 between D17S33 and D17S57, markers that also flank NF1 within a region of 4 cM. These data are consistent with the possibility that the translocation event is the cause of NF1 in this pedigree. Consequently, the isolation of the translocation breakpoint, by approach from either the chromosome 1 or the chromosome 17 side, may facilitate the identification of the NF1 gene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507442     DOI: 10.1016/0888-7543(89)90053-0

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  12 in total

1.  Refined physical and genetic mapping of the NF1 region on chromosome 17.

Authors:  P R Fain; D E Goldgar; M R Wallace; F S Collins; E Wright; K Nguyen; D F Barker
Journal:  Am J Hum Genet       Date:  1989-11       Impact factor: 11.025

2.  Genetic and physical map of the von Recklinghausen neurofibromatosis (NF1) region on chromosome 17.

Authors:  M K Yagle; G Parruti; W Xu; B A Ponder; E Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 3.  Clinical and genetic patterns of neurofibromatosis 1 and 2.

Authors:  N K Ragge
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

4.  The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin.

Authors:  G R Skuse; B A Kosciolek; P T Rowley
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

5.  Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers.

Authors:  A Ziegler; D J Leffell; S Kunala; H W Sharma; M Gailani; J A Simon; A J Halperin; H P Baden; P E Shapiro; A E Bale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

6.  Predisposition for breast cancer in carriers of constitutional translocation 11q;22q.

Authors:  A Lindblom; K Sandelin; L Iselius; J Dumanski; I White; M Nordenskjöld; C Larsson
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

7.  A small deletion and an adjacent base exchange in a potential stem-loop region of the neurofibromatosis 1 gene.

Authors:  M Stark; G Assum; W Krone
Journal:  Hum Genet       Date:  1991-10       Impact factor: 4.132

8.  Recurrence of a nonsense mutation in the NF1 gene causing classical neurofibromatosis type 1.

Authors:  X Estivill; C Lázaro; T Casals; A Ravella
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

9.  Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome.

Authors:  M Tassabehji; T Strachan; M Sharland; A Colley; D Donnai; R Harris; N Thakker
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

10.  The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene.

Authors:  D Viskochil; R Cawthon; P O'Connell; G F Xu; J Stevens; M Culver; J Carey; R White
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.